Page last updated: 2024-12-06
amphenone b
Description
Amphenone B is a synthetic compound that acts as an inhibitor of steroid biosynthesis. Its mechanism of action involves blocking the enzyme 11β-hydroxylase, which is essential for the production of cortisol and aldosterone. Amphenone B was initially studied for its potential therapeutic applications in the treatment of Cushing's syndrome, a condition characterized by excessive cortisol production. However, its clinical use was limited due to its significant side effects, including adrenal insufficiency and hepatotoxicity. Despite its limited clinical use, Amphenone B continues to be studied for its potential applications in research, particularly in the development of new drugs for the treatment of steroid hormone-dependent diseases.'
amphenone B: was MH 1975-92 (see under BUTANONES 1975-90); use BUTANONES to search AMPHENONE B 1975-92 [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
PubMed CID | 17591 |
CHEBI ID | 2678 |
SCHEMBL ID | 8333956 |
MeSH ID | M0198142 |
Synonyms (18)
Synonym |
2686-47-7 |
amphenone b |
C07616 |
3,3-bis(4-aminophenyl)butan-2-one |
AC1L2AAH , |
2-butanone, 3,3-bis(4-aminophenyl)- |
unii-y2yun941sl |
y2yun941sl , |
3,3-bis(4-aminophenyl)-2-butanone |
amphenone b [mi] |
amphenone |
2-butanone, 3,3-bis(p-aminophenyl)- |
CHEBI:2678 |
SCHEMBL8333956 |
surecn8333956 |
DTXSID70181370 |
amphenon b |
Q27105763 |
Drug Classes (1)
Class | Description |
diarylmethane | Any compound containing two aryl groups connected by a single C atom. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Research
Studies (19)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 19 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 16.54
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 16.54 (24.57) | Research Supply Index | 3.09 (2.92) | Research Growth Index | 4.45 (4.65) | Search Engine Demand Index | 10.37 (26.88) | Search Engine Supply Index | 2.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 21 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |